Vinorelbine Tartrate Injection Clinical Trials

3 actively recruiting trials

Pipeline

Phase 3: 2Phase 1/2: 1

Top Sponsors

Shanghai Yizhong Pharmaceutical Co., Ltd.1
Jiangsu Alphamab Biopharmaceuticals Co., Ltd1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Indications

Breast Cancer3
Cancer3
Metastatic Breast Cancer (MBC)1
Recurrent Breast Cancer1
Advanced Malignancies1

Other3 trials

A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

Phase 1/2

Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer

Phase 3

JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.